EBITDA for Baxter International (BAX)
According to Baxter International's latest reported financial statements, the company's current EBITDA (TTM) is $766.00M USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$766.00M
YoY change
-31.4%
5Y CAGR
-19.5%
Peak year (2016)
$5.84B
Cumulative EBITDA
$73.35B
EBITDA history chart for Baxter International (BAX) from 1985 to 2025
EBITDA history table for Baxter International (BAX) from 1985 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $766.00M | -31.4% | ||
| 2024 | $1.12B | -35.6% | ||
| 2023 | $1.73B | -198.4% | ||
| 2022 | -$1.76B | -180.5% | ||
| 2021 | $2.19B | -3.4% | ||
| 2020 | $2.27B | +21.3% | ||
| 2019 | $1.87B | -24.6% | ||
| 2018 | $2.48B | +28.2% | ||
| 2017 | $1.94B | -66.9% | ||
| 2016 | $5.84B | +338.3% | ||
| 2015 | $1.33B | -8.0% | ||
| 2014 | $1.45B | +24.4% | ||
| 2013 | $1.17B | -68.2% | ||
| 2012 | $3.66B | +2.6% | ||
| 2011 | $3.57B | +32.8% | ||
| 2010 | $2.69B | -22.9% | ||
| 2009 | $3.49B | +7.7% | ||
| 2008 | $3.24B | +15.0% | ||
| 2007 | $2.82B | +16.7% | ||
| 2006 | $2.42B | +14.5% | ||
| 2005 | $2.11B | +3.5% | ||
| 2004 | $2.04B | -4.7% | ||
| 2003 | $2.14B | -0.8% | ||
| 2002 | $2.16B | +11.8% | ||
| 2001 | $1.93B | +12.6% | ||
| 2000 | $1.71B | +12.6% | ||
| 1999 | $1.52B | +12.0% | ||
| 1998 | $1.36B | +12.8% | ||
| 1997 | $1.21B | -4.3% | ||
| 1996 | $1.26B | +9.5% | ||
| 1995 | $1.15B | -25.7% | ||
| 1994 | $1.55B | +111.1% | ||
| 1993 | $733.00M | -50.9% | ||
| 1992 | $1.49B | -1.5% | ||
| 1991 | $1.51B | +103.4% | ||
| 1990 | $745.00M | -38.0% | ||
| 1989 | $1.20B | +11.3% | ||
| 1988 | $1.08B | +7.4% | ||
| 1987 | $1.01B | +31.0% | ||
| 1986 | $768.00M | +92.5% | ||
| 1985 | $399.00M | — |
EBITDA values are taken from Baxter International's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Baxter International (BAX) EBITDA is $766.00M – plunged 31.4% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Baxter International EBITDA compounded at -19.5% per year, with a net decline across the window.
Between 2016 and 2025, Baxter International EBITDA plunged 86.9%, falling from $5.84B to $766.00M.
The highest annual EBITDA of $5.84B was reported in 2016. The lowest in the available history was -$1.76B in 2022.
Within Healthcare, Baxter International (BAX) ranks 9th among 8 peers we track. The peer median for EBITDA is $24.21B.
Baxter International EBITDA by Year
Baxter International EBITDA 2025: $766.00M
Baxter International EBITDA in 2025 was $766.00M, plunged 31.4% below 2024.
Baxter International EBITDA 2024: $1.12B
Baxter International EBITDA in 2024 was $1.12B, plunged 35.6% below 2023.
Baxter International EBITDA 2023: $1.73B
Baxter International EBITDA in 2023 was $1.73B, plunged 198.4% below 2022.
Baxter International EBITDA 2022: -$1.76B
Baxter International EBITDA in 2022 was -$1.76B, plunged 180.5% below 2021. This figure represents the lowest annual value in the available history.
Baxter International EBITDA 2021: $2.19B
Baxter International EBITDA in 2021 was $2.19B.
See more financial history for Baxter International (BAX).
Sector peers — EBITDA
Companies in the same sector as Baxter International, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Baxter International's EBITDA?
- Latest reported EBITDA for Baxter International (BAX) is $766.00M (period ending December 31, 2025).
How has Baxter International EBITDA changed year-over-year?
- Baxter International (BAX) EBITDA changed -31.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Baxter International EBITDA?
- Baxter International (BAX) EBITDA compound annual growth rate is -19.5% over the most recent 5 years available.
When did Baxter International EBITDA hit its highest annual value?
- Baxter International EBITDA reached its highest annual value of $5.84B in 2016.
What was Baxter International EBITDA in 2024?
- Baxter International (BAX) EBITDA in 2024 was $1.12B.
What was Baxter International EBITDA in 2025?
- Baxter International (BAX) EBITDA in 2025 was $766.00M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BAX Overview
Company profile, financial tools, and key metrics
BAX Revenue Counter
Earns $356.54 every second. See per minute, hour, and day.
BAX Earnings Counter
Loses −$30.35 per second. See per minute, hour, and day.
BAX Economic Scale
Exceeds Monaco's GDP. Compare with world economies.
BAX What If Invested
What if you had invested $1,000? See historical returns from any date.
BAX How It Makes Money
Discover visual breakdown of $11.24B in revenue — where it comes from and where it goes.
BAX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BAX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BAX Daily Price Character
Steady · 48.3% historical win rate (green days). Streaks & record days.
BAX Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BAX Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
BAX Dividend Profile
Yield: 2.13%. Safety: 3/8. See full history.
BAX Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BAX Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.